These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12549)

  • 21. Response of tyrosine hydroxylase and GTP cyclohydrolase I gene expression to estrogen in brain catecholaminergic regions varies with mode of administration.
    Serova LI; Maharjan S; Huang A; Sun D; Kaley G; Sabban EL
    Brain Res; 2004 Jul; 1015(1-2):1-8. PubMed ID: 15223360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and histofluorescence studies of catecholamines in superior cervical ganglia in organ culture.
    Webb JG; Moss J; Kopin IJ; Jacobowitz DM
    J Pharmacol Exp Ther; 1975 May; 193(2):489-502. PubMed ID: 238022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a TRH analog (DN-1417) on tyrosine hydroxylase activity in discrete areas of rat brain.
    Yokoo H; Nakahara T; Uchimura H; Matsumoto T; Hirano M
    Kurume Med J; 1983; 30 Suppl():S37-43. PubMed ID: 6148453
    [No Abstract]   [Full Text] [Related]  

  • 25. Responsiveness to d-amphetamine in lead-exposed rats as measured by steady state levels of catecholamines and locomotor activity.
    Rafales LS; Greenland RD; Zenick H; Goldsmith M; Michaelson IA
    Neurobehav Toxicol Teratol; 1981; 3(3):363-7. PubMed ID: 7290291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A possible mechanism for the anti-depressant activity of thyrotropin releasing hormone.
    Horst WD; Spirt N
    Life Sci; 1974 Sep; 15(6):1073-82. PubMed ID: 4157277
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of clonidine on tyrosine hydroxylase activity in the adrenal medulla and brain of spontaneously hypertensive rats.
    Moura E; Afonso J; Serrão MP; Vieira-Coelho MA
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):113-21. PubMed ID: 19067675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
    Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
    Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
    Ijiro T; Nakamura K; Ogata M; Inada H; Kiguchi S; Maruyama K; Nabekura J; Kobayashi M; Ishibashi H
    Eur J Pharmacol; 2015 Aug; 761():413-22. PubMed ID: 26142830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of repeated D-lysergic acid diethylamide injections on catecholamine levels and tyrosine hydroxylase activity in rat brain regions.
    Peters DA; Tang S
    J Neurochem; 1977 Jan; 28(1):59-62. PubMed ID: 13158
    [No Abstract]   [Full Text] [Related]  

  • 32. Lithium suppresses elevated behavioural activity and brain catecholamines in developing hyperthyroid rats.
    Rastogi RB; Singhal RL
    Can J Physiol Pharmacol; 1977 Jun; 55(3):490-5. PubMed ID: 18270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice.
    Ushijima I; Yamada K; Furukawa T; Noda Y; Todoroki M; Inanaga K
    Arch Int Pharmacodyn Ther; 1980 Oct; 247(2):257-63. PubMed ID: 6778401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 35. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thyrotropin- and corticotropin-releasing hormone on blood pressure and plasma catecholamines in the anesthetized rat.
    Schulz C; Christodulopulu E; Bock A; Kretz M; Beyer J; Lehnert H
    Neuropsychobiology; 1994; 30(4):178-84. PubMed ID: 7862266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.
    Dairman W
    Br J Pharmacol; 1972 Feb; 44(2):307-10. PubMed ID: 4148919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of phencyclidine on the accumulation of 14 C-catecholamines formed from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):252-8. PubMed ID: 4694363
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of interferon-alpha on tyrosine hydroxylase and catecholamine levels in the brain of rats.
    Kumai T; Tateishi T; Tanaka M; Watanabe M; Shimizu H; Kobayashi S
    Life Sci; 2000 Jun; 67(6):663-9. PubMed ID: 12659172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of tyrosine in the acute effects of ethanol on rat brain catecholamine synthesis.
    Badawy AA; Williams DL; Evans M
    Pharmacol Biochem Behav; 1983; 18 Suppl 1():389-96. PubMed ID: 6138774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.